Quick Overview: In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic ... In this podcast, Anne E. O'Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis ... This session will discuss new advances in airway stem cells models and how these can be applied for studying chronic lung ...
Innovations In Ncfbe Understanding The - Detailed Overview & Context
In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic ... In this podcast, Anne E. O'Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis ... This session will discuss new advances in airway stem cells models and how these can be applied for studying chronic lung ... Yale School of Medicine shares how it uses an Marten deVlieger, from Canada, and his sister, were diagnosed with Cystic Fibrosis, when he was two months old. His disease ... This workshop includes abstracts that highlight unique clinical research strategies and methods for study teams. This session ...
Before a potential new drug is tested in people with cystic fibrosis in clinical trials, it must go through preclinical development. The COVID-19 pandemic has drastically transformed the way we provide medical care to persons with cystic fibrosis over the last ... This session features presentations about recent quality improvement (QI) projects and best practices related to clinical research. Pitt Center for Vaccine Research co-director Ron Montelaro, Ph.D., stumbled upon a promising new antibiotic for the treatment of ... Scientists are creating mini-organs in the lab by using a patient's own stem cells, aiming at treating very rare types of ... Created in collaboration with Horizon Respirologists, this animated video explores cystic fibrosis (CF), a genetic disorder that ...
Course director, David J. Lederer, MD, MS discusses Idiopathic Pulmonary Fibrosis in this CME activity titled Personalizing ... Gene editing, the ability to precisely correct CF-causing variants in the CFTR gene, is a key pillar of Path to a Cure.
